ISR Phase II/III CRO Benchmarking Report 2024

Read more

On May 1st, Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports. The CRO Leadership Awards recognize Phase 1 and Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability. 2024 marks the 11th consecutive year that Worldwide has been rated as a high-performing CRO based on primary market research. The 2024 data show that Worldwide outperformed other Phase 2/3 CROs for Project Manager Quality and Worldwide achieved top marks across all five categories and was honored as a “Champion” in several categories across Big Pharma.

Want to learn more about Worldwide Clinical Trials?